Tag: European Academy of Allergy Asthma and Immunology (EAACI)

Research

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
AR101

Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...

“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
AR101

European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...

Company Intends to Submit European MAA in Mid-2019.
AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.

Connect with Us

39,161FansLike
782FollowersFollow
2,716FollowersFollow
5,529FollowersFollow
40SubscribersSubscribe